1,25-Dihydroxyvitamin D <sub>3</sub> Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
Sneha Joshi(Rutgers, The State University of New Jersey), Sawsan Youssef(Stanford University), Sarah L. Gaffen(University of Pittsburgh), Xikui K. Liu(University at Buffalo, State University of New York), Lawrence Steinman(Stanford University), Christine Rohowsky‐Kochan(Rutgers, The State University of New Jersey), Sylvia Christakos(Rutgers New Jersey Medical School), Hong Liu(Yantai Infectious Diseases Hospital), Akihiko Yoshimura(Kyushu University), Luiz-Carlos Pantalena(Stanford University), Kenji Ichiyama(The University of Osaka)
Cited by 456
Related Papers
Regulatory T Cells and Human Disease
|Annual Review of Immunology|2020|1.1k
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
|The Journal of Experimental Medicine|2009|999
A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors.
|The EMBO Journal|1995|758
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
|Nature Medicine|2007|448